Immunohistochemical analysis confirmed that de novo methyltransferase DNMT3a and DNMT3b were significantly decreased in chronic asthma compared with the control group, and was especially expressed in bronchial epithelium (Figure 3C). This evidence concerns the gene DNMT3A and chronic asthma.